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ABSTRACT
Many eukaryotic and viral mRNAs, in which the first
transcribed nucleotide is an adenosine, are
decorated with a cap-1 structure,
7MeG
50
-ppp
50
-
A20OMe. The positive-sense RNA genomes of
flaviviruses (Dengue, West Nile virus) for example
show strict conservation of the adenosine. We set
out to produce GpppA- and
7MeGpppA-capped RNA
oligonucleotides for non-radioactive mRNA cap
methyltransferase assays and, in perspective, for
studies of enzyme specificity in relation to substrate
length as well as for co-crystallization studies.
This study reports the use of a bacteriophage
T7 DNA primase fragment to synthesize GpppACn
and
7MeGpppACn (1 n 9) in a one-step enzymatic
reaction, followed by direct on-line cleaning HPLC
purification. Optimization studies show that yields
could be modulated by DNA template, enzyme
and substrate concentration adjustments and
longer reaction times. Large-scale synthesis
rendered pure (in average 99%) products (1 n 7)
in quantities of up to 100nmol starting from
200nmol cap analog. The capped RNA oligonucleo-
tides were efficient substrates of Dengue virus
(nucleoside-20-O-)-methyltransferase, and human
(guanine-N7)-methyltransferase. Methyltransfer
reactions were monitored by a non-radioactive,
quantitative HPLC assay. Additionally, the produced
capped RNAs may serve in biochemical, inhibition
and structural studies involving a variety of
eukaryotic and viral methyltransferases and
guanylyltransferases.
INTRODUCTION
The cap is a unique structure at the 50-end of viral and
cellular eukaryotic mRNAs (1,2). It is critical for
both mRNA stability and binding to the ribosome
during translation. Cap 0 (
7MeG
50
-ppp
50
-N) formation
is a co-transcriptional modiﬁcation resulting from three
enzymatic activities: RNA triphosphatase, guanylyltrans-
ferase and S-adenosyl-L-methionine (AdoMet) dependent
(guanine-N7)-methyltransferase (N7MTase). Further
methylation at the 20O position of the ribose of the ﬁrst
nucleotide by an AdoMet-dependent (nucleoside-20-O-)-
methyltransferase (20OMTase) leads to a cap 1 structure
(
7MeG
50
-ppp
50
-N20OMe). Capped RNA molecules are
required as substrates for the biochemical characterization
of mRNA cap MTases, as well as structural studies on
guanylyltransferases and MTases complexed with pro-
ducts or substrates, and they are not commercially
available.
The single-stranded positive-sense RNA genome of
ﬂaviviruses is decorated with a cap 1 structure. The genus
Flavivirus contains at least 70 viruses (3), among them
emerging human pathogens such as Dengue, West Nile
and Japanese encephalitis virus (4), all of which bear
a
7MeG
50
-ppp
50
-A20OMe cap structure with a strictly
conserved adenosine as ﬁrst nucleotide. We set out to
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(7Me)GpppA-capped (i.e. GpppA- or
7MeGpppA-)
RNA molecules to aid our studies on the capping
machinery of ﬂaviviruses (5,6).
In order to get GpppA-capped RNAs, several
approaches can be taken that diﬀer widely in their
eﬃciency. They can be synthesized chemically starting
from mono- or diphosphate RNA (7,8). A
7MeGpppA cap
can also be added to di- or triphosphate RNA using
vaccinia virus capping enzyme that contains RNA triphos-
phatase, guanylyltransferase and N7MTase activities
(9,10). However, diphosphate and triphosphate RNAs
are not commercially available.
(7Me)GpppA can be
incorporated upon in vitro transcription by bacteriophage
T7, T3 or SP6 DNA-dependent RNA polymerases
(DdRp) (e.g. (11)) using their respective promoters and
an adenosine in position þ1o rþ2 (12,13). The eﬃciency
of these reactions is rather low because these promoters
require a guanine as starting nucleotide. Very recently,
an alternative, the bacteriophage T7 class II f2.5
promoter (14) which requires an adenosine as ﬁrst trans-
cribed nucleotide, was successfully applied to generate
GpppA-capped transcripts (15). (7Me)GpppA was reported
to be incorporated upon in vitro transcription by E. coli
DdRp using the bacteriophage  PL promoter (16),
a method that has not been exploited since. Finally,
very short capped oligonucleotides
(7Me)GpppACC were
produced eﬃciently using bacteriophage T7 DNA
primase-helicase (17).
Here we report the adaptation of the latter approach to
prepare large amounts of capped RNA oligonucleotides
7MeGpppACn and GpppACn with a range of chain lengths
(1 n 7). Instead of the full-length bacteriophage
T7 DNA primase-helicase, we used a recombinant
N-terminal fragment of 30kD bearing the primase activity
(18,19). The use of the fragment oﬀers several advantages
regardingenzymeproductionandpuriﬁcationcomparedto
the full-length protein namely a 10 to 20 times higher
relative expression yield, higher solubility and the fact
that it does not co-purify with DNA (19). The DNA
primase fragment was reported to show similar activity to
the full-length protein when using high DNA template
concentrations (19). Nevertheless, production of short-
capped RNA oligonucleotides
7MeGpppAC2 that has
been shown for full-length protein (17), has never been
demonstratedfortheDNAprimasefragment.Inthiswork,
we synthesized
7MeGpppAC2 and GpppAC2 as well as
longer products using the DNA primase fragment. After
undertakingoptimizationstudies,wedesignedarobustand
eﬀective method to produce high amounts of pure
(7Me)GpppACn (1 n 7). Given the lack of commercial
availability of capped RNA oligonucleotides we expect
this method to be useful for many researchers
working in the still emerging ﬁeld of characterization
of viral and mammalian RNA capping machineries.
In addition, we demonstrate that the produced GpppA-
capped RNAs are substrates of Dengue virus 20OMTase
and human mRNA cap N7MTase. Both methyltransferase
reactions were monitored by a non-radioactive, quantita-
tive assay based on HPLC and the reaction products were
characterized.
MATERIAL AND METHODS
Protein expression and purification
T7 DNA primase fragment. The T7 DNA primase
expression vector pET19b/PrD was kindly provided by
Charles C. Richardson (Harvard Medical School, Boston,
USA). E. coli BL21(DE3) cells (500ml) transformed with
pET19b/PrDT were grown in Luria-Bertani medium
containing ampicillin. At an OD600 of 0.6 isopropyl
b-D-thiogalactopyranoside (IPTG) was added to a ﬁnal
concentration of 200mM, and expression was allowed
to proceed for 2h at 378C. The cellular pellet was
resuspended in 10ml lysis buﬀer (50mM HEPES,
pH 7.5, 100mM NaCl, 5mM b-mercaptoethanol, 1mM
phenylmethylsulfonyl ﬂuoride (PMSF)) supplemented
with 1mM benzamidine, 10mM imidazole, 100mg/ml
lysozyme and 1mg/ml DNAse I. Since the expressed
protein bears a His-tag at the N-terminus, immobilized-
metal-aﬃnity chromatography (IMAC) was used for the
ﬁrst puriﬁcation step (chelating sepharose fast ﬂow resine
(Amersham Biosciences) loaded with Ni
2þ). The protein
was eluted with lysis buﬀer containing 250mM imidazole.
Fractions were then directly loaded onto a HiTrap DEAE
Sepharose FF 1-ml column (Amersham Biosciences)
equilibrated with 50mM HEPES, pH 7.5, containing
0.1mM DTT, and eluted with a gradient of NaCl
(0–500mM). The protein elutes at 200mM NaCl.
The sample was diluted to lower the NaCl concentration
to 50mM and loaded onto a HiTrap Blue Sepharose 1-ml
column (Amersham Biosciences) equilibrated with 50mM
HEPES, pH 7.5, containing 1mM DTT and 1mM
EDTA. Elution was carried out with a gradient of NaCl
(0–800mM). Glycerol was added to reach 50% and
the protein stored at  208C.
Dengue virus MTase domain (NS5MTaseDV). Recom-
binant NS5MTaseDV was produced as described in (6).
Human MTase (hMTase). The cDNA coding for
hMTase was a kind gift from Aaron J. Shatkin (Center
of Advanced Biotechnology and Medicine, Piscataway,
USA.). It was ampliﬁed by PCR using primers
RBSATGLys6HishMTs 50-CCATGAAACATCACCAT
CACCATCACGCAAATTCTGCAAAAGCAGAAG-30
and hMTstopattb2as 50-GGGGACCACTTTGTACAAG
AAAGCTGGGTCTTACTGCTGTTTCTCAAAGGCA
AAC-30. A second PCR was then used to add the attb1
recombination site to the 50 using primers attB1RBS
ATGLys6His 5
0
-GGGGACAAGTTTGTACAAAAAAG
CAGGCTTCTAAGGAGGTAGAACCATGAAACAT
CACCATCACCATCAC-30 and hMTstopattb2as given
above. The PCR product was then cloned into
the expression vector pDest14 (Invitrogen) using the
Gateway technology. E. coli Rosetta(DE3) cells were
transformed with pDest14/6His-hMTase and grown
in Luria-Bertani medium containing ampicillin and
chloramphenicol. At an OD600 of 0.6, IPTG and ethanol
were added to a ﬁnal concentration of 100mM and 2%,
respectively, and expression was allowed to proceed
for 18h at 178C. The cellular pellet was resuspended in
10ml lysis buﬀer (50mM Tris, pH 8.5, 300mM NaCl,
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cocktail (Complete , Roche)) supplemented with 10mM
imidazole, 100mg/ml lysozyme and 1mg/ml DNAse I
and 0.5% triton X100. After lysis by sonication and
clariﬁcation, immobilized-metal-aﬃnity chromatography
(IMAC) was used for the ﬁrst puriﬁcation step (chelating
sepharose fast ﬂow resine (Amersham Biosciences)
loaded with Ni
2þ). The hMTase was eluted with lysis
buﬀer pH 7.5 containing 250mM imidazole. Fractions
were then diluted 5 times in 50mM Bis-Tris pH 6.8;
50mM NaCl, 10% glycerol, 5mM b-mercaptoethanol,
and loaded onto a 5-ml heparine column (Amersham
Biosciences). The hMTase was then eluted with a
gradient of NaCl (0–1M) using a buﬀer at pH 7.5.
The protein elutes at between 150 and 350mM NaCl.
It was ﬁnally dialyzed against 50mM Tris, pH 7.5,
300mM NaCl, 50% glycerol, 5mM b-mercaptoethanol
and stored at  208C.
HPLC set-up
A Waters model 600 gradient HPLC system equipped with
two 600 pumps, a 717 plus Autosampler injector, a 996
photodiode array detector and an in-line degasser AF was
employed for reverse-phase chromatography. The column
assembly consisting of a pre-column (Delta-pak C18
100A ˚ ,5 mm, 3.9 20mm) and the separation column
(Nova-pak C18, 4mm, 3.9 150mm) was protected by a
ﬁlter insert. For the on-line cleaning procedure, both
columns were installed in parallel on a two 7000 Rheodyne
valve system (Interchim). As buﬀer stock solution, a 1M
solution of triethylammonium bicarbonate (TEAB) was
prepared by adding dry-ice to a 1M triethylamine solution
until the pH reached 7.4 and ﬁltered through 0.22mM GV-
type membranes (Millipore). HPLC eluents were freshly
prepared. Eluent A was a 0.05M solution of TEAB
(pH 7.4) and eluent B was a 1:1, v/v, mixture
of acetonitrile (HPLC grade, SDS) and TEAB (ﬁnal
concentration 0.05M, pH 7.4). Separations were run at a
ﬂow rate of 1ml/min and started with a 5-min elution
(100% eluent A) on the pre-column to remove proteic
material. The applied gradients for analytical and
preparative separation of capped RNAs as well as for
analysis of methyltransferase reactions are explained in
the corresponding sections (see below).
Mass spectrometry analysis
MALDI-TOF mass spectra were recorded on a Voyager
DE mass spectrometer (Perseptive Biosystems) equipped
with an N2 laser (337nm). MALDI conditions were:
accelerating potential, 24000V; guide wire, 0.05% of
accelerating voltage; grid voltage, 94% of accelerating
voltage; delay extraction time, 550ns. Spectra were
obtained in negative mode and were not smoothed. The
oligonucleotides (100pmol) were suspended in 10mlo f
water and desalted using drop dialysis through a
membrane ﬁlter WSWP 0.025mm, 13mm (Millipore)
ﬂoating on a 0.1M ammonium citrate solution for
30min. When drop dialysis did not allow to remove
totally salt traces, the samples were further treated with a
few beads of DOWEX 50W X8 resin (ammonium form)
before spotting them on the MALDI target. Samples of
0.5ml were mixed with 0.5ml of the matrix 2,4,6-
trihydroxyacetophenone (THAP, 45mg, ammonium
citrate, 4mg in 500ml acetonitrile/water, 1:1, v/v) and
the mixtures were spotted on the stainless steel MALDI
target and left to dry under air before MALDI analysis.
Capped RNA synthesis
Analytical scale. Experiments were carried out in 20–40ml
reaction volume containing T7 DNA primase reaction
buﬀer (40mM Tris pH 7.5, 10mM MgCl2,5 0 m M
potassium glutamate, 1mM ZnCl2), 10mM DTT and
50mg/ml BSA as well as CTP (Amersham Biosciences),
cap analog (New England Biolabs), DNA oligonucleo-
tides (Invitrogen, HPLC grade) and enzyme at concentra-
tions given in table and ﬁgure legends. Reaction mixtures
were set up and incubated at 378C for time intervals given
in table and ﬁgure legends. Reactions were stopped
by heating the samples at 958C for 5min and stored
at  208C. For HPLC analysis 20ml of sample were
mixed with 200ml of TEAB (0.05M) and analyzed.
The analytical gradient started after 5min at 100%
eluent A with an increase to 10% eluent B after 25min,
to 30% eluent B after 35min and to 50% eluent B after
40min. Reaction yields were calculated from HPLC peak
areas considering diﬀerences in absorbance due to molar
absorptivities e increasing with increasing chain length.
The e260 values (M
 1cm
 1) of GpppA and
7MeGpppA
were calculated as 26900 (11500Gþ15400A) and 25500,
respectively. e260 values of G (11500),
7MeG (10100) and
A (15400) were taken from http://www.owcsarzy.net/
emethod.htm and (20). e260 values of products
were calculated using the nearest neighbor method
(see http://www.owcsarzy.net/emethod.htm and (21)).
e260 of GpppACC was calculated as 31200 (11500Gþ
21000ApCþ14200CpC 7200C). Values of methylated and
longer products were calculated likewise. Yields of total
product are given as percentage of substrate (cap analog)
conversion. Additionally, from these values, yields were
converted into pmol product, which can then be related
to the amount of enzyme (pmol) used to generate the
determined amount of product. Yields of single products
are given in percentage of substrate (cap analog) conver-
sion or in percentage of total product (explained in ﬁgure
or table legends).
Preparative scale. Samples were set up in 200ml reaction
volume containing T7 DNA primase reaction buﬀer,
10mM DTT and 50mg/ml BSA, 5mM CTP, 1mM cap
analog, 10mM DNA template and 4mM T7 DNA
primase. Reactions were incubated at 378C during time
intervals given in Table 3, stopped by heating at 958C for
5min and stored at  208C. Samples of 50ml were mixed
with 200ml of TEAB (0.05M) and analyzed. Preparative
gradient started after 5min at 100% eluent A with an
increase to 10% eluent B after 30min and to 30% after
45min. After peak separation and collection, the samples
were lyophilized three times and resuspended in water.
Their purity was veriﬁed by HPLC, their concentration
determined by measuring OD260 values and their
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preparative reactions are given as isolated yields based on
measured amounts of products (absorbance measure-
ments of pure products after lyophilization using molar
absorptivities calculated as given above) and the
amount of substrate used (Table 3). Samples were stored
at  208C.
Methyltransferase experiments
Dengue virus MTase domain. The reaction was set up in
50ml reaction volume containing 40mM Tris, pH 7.5,
5mM DTT, 500nM NS5MTaseDV,2 mM GpppAC3 and
20mM AdoMet, incubated for 60min at 308C
and stopped by immediate freezing. For HPLC
analysis, the sample was mixed with 210ml of TEAB
(0.05M) and analyzed. The gradient started after
5min at 100% eluent A with an increase to 10%
eluent B after 25min, and to 30% eluent B after 45min.
The product peak was puriﬁed and analyzed by mass
spectrometry.
Human N7 MTase. Reactions were set up in 40ml
reaction volume containing 40mM Tris, pH 7.5, 5mM
DTT, 500nM hMTase, 2mM capped RNA oligonucleo-
tide and 10mM AdoMet. Reactions were incubated for
30min at 308C and stopped by immediate freezing. For
HPLC analysis, 40ml of sample were mixed with 210mlo f
TEAB (0.05M) and analyzed. The gradient started
after 5min at 100% eluent A with an increase to 10%
eluent B after 25min, and to 30% eluent B after 45min.
The product peak was puriﬁed and analyzed by mass
spectrometry.
Analysis of GpppA20OMeC3 by enzymatic digestion and
HPLC
A preparative reaction (3 250ml) was set up using the
same conditions as described above for Dengue virus
MTase except that 1mM NS5MTaseDV was used and the
reaction stopped after 8h. Samples of 250ml reaction
mixture were mixed with 750ml of TEAB (0.05M) and
injected into the HPLC system. The gradient started after
5min at 100% eluent A with an increase to 10% eluent B
after 25min and to 20% after 35min. After peak
separation and collection, the product was lyophilized
three times. Product yield was around 1nmol of pure,
lyophilized GpppA20OMeC3.T h e n0 . 5n m o lG p p p A 20OMeC3
was digested in 20ml reaction volume containing 50mM
Tris, pH 8.5, 5mM MgCl2, 0.05 units of nucleotide
pyrophosphatase type II from Crotalus adamanteus
(Sigma, enzyme preparation contains side activity phos-
phodiesterase I, 0.005 units in 20ml reaction volume) and
10 units of calf intestine phosphatase (New England
Biolabs). Reaction was allowed to proceed for 11min at
378C and stopped by heating to 958C for 5min. The crude
reaction mixture was then diluted with water (120ml),
ﬁltered on Nanosep 3K omega (Pall Corporation) and
centrifuged at 16000 g for 20min. Washing of the ﬁlter
was done by adding 60ml of water followed by centrifuga-
tion at 16000 g for 10min. The combined ﬁltrates were
mixed with 200ml of TEAB (0.05M) and analyzed by
HPLC without using the on-line cleaning procedure.
The gradient started after 5min at 100% eluent A with
an increase to 10% eluent B after 25min and to 30%
after 45min.
RESULTS AND DISCUSSION
Synthesis of
(7Me)GpppACn by T7 DNA primase
Bacteriophage T7 DNA primase-helicase is able to
synthesize small RNA primers with the sequence
pppA(C)n (n¼3,4) from DNA templates containing the
recognition sequence
50
GTC
30
in which the cytidine
is cryptic (22). The initiation site being ﬂexible in terms
of the phosphate moiety of the initiating adenosine (23)
can accommodate GpppA or
7MeGpppA allowing thus the
production of capped RNA oligonucleotides (17). For this
study, we used the N-terminal fragment of the protein
(residues 1 to 271), which contains the N-terminal
Zn-binding domain (residues 1 to 56) and the catalytic
RNA polymerase domain (residues 71–245) connected by
a ﬂexible linker (18). The DNA primase fragment was
eﬃciently expressed in E. coli, soluble and easily puriﬁed
(see Material and Methods).
We started with a DNA template, CCCCGGGTCT25
(transcribed sequence underlined) designed for the synth-
esis of AC3. Instead of the initiating ATP, we used GpppA
and
7MeGpppA in order to produce
(7Me)GpppAC3.
Product formation was analyzed by reverse-phase
chromatography on a HPLC system. An ‘on-line cleaning’
process (24,25) was used to remove unwanted proteic
material from the sample. This technique allowed direct
analysis of crude enzymatic reaction mixtures, with no
signiﬁcant loss of material. The sample was loaded
onto the pre-column, thus eliminating proteic material
while retaining the oligonucleotide mixture. After 5min,
the ﬂow path was inverted and the substrates and
produced capped RNAs were delivered onto the separat-
ing column by starting an acetonitrile gradient. Figure 1
shows the proﬁles after 6h of primase reaction. Single
peak material was puriﬁed and the molecular masses
determined by mass spectrometry (see Material and
Methods). Substrates GpppA and
7MeGpppA were eﬃ-
ciently incorporated by T7 DNA primase into small-
capped RNAs
(7Me)GpppACn (1 n 4). Apart from the
main product
(7Me)GpppAC3, smaller products were gen-
erated,
(7Me)GpppAC and to a lower extent
(7Me)GpppAC2
(not labeled in Figure 1), as well as a longer product,
(7Me)GpppAC4. The long DNA template size which was
chosen albeit the primase fragment works equally on short
templates (26), allowed its easy separation from the
reaction products because of its longer retention time
(38.3min).
Subsequently, we followed product formation over time
in order to reach optimal substrate conversion (Figure 2).
Figure 2A shows the overall yield when GpppA or
7MeGpppA were used as cap analogs. T7 DNA primase
incorporates both to same extent. Reactions were com-
pleted to 96% after 21h. Figure 2B shows accumulation
of individual products GpppAC to GpppAC5 of one
e26 Nucleic Acids Research, 2007, Vol. 35, No. 4 PAGE4 OF 11of the reactions using GpppA as cap analog. GpppAC
was produced during the early phase of reaction and
completely converted into longer products after 16h.
GpppAC2 was equally only present during the early phase
of the reaction but to very low extent. After 1h, GpppAC3
was the main product and remained so throughout the
reaction. GpppAC4 appeared almost immediately and
its yield grew linearly, whereas GpppAC5 appeared after
15h. Thus leaving the reaction longer opens the possibility
to produce higher amounts of longer substrates
(see below). The product proﬁles were similar when
7MeGpppA was used as cap analog (not shown).
Higher accumulation of AC than of AC2 products
has been observed repeatedly (27,28). Recently, it was
proposed that the accumulation of the abortive AC
product results from a change in conformation, namely
in the relative position of the Zn-binding and RNA
polymerase domains, occurring after the synthesis of the
ﬁrst phosphodiester bond so that the AC product
is released more readily (29). Once the elongation-mode
conformation is in place, longer products are formed.
As it has been described before for non-capped RNA
oligonucleotide synthesis by T7 DNA primase (22,27,28),
the primase added extra non-templated cytidines
and thus produced
(7Me)GpppAC4 and
(7Me)GpppAC5.
This phenomenon might be due to either the ability
of the primase to mis-incorporate CMP opposite
Figure 1. HPLC proﬁles of T7 DNA primase reaction mixtures using
DNA template CCCCGGGTCT25. Crude enzymatic mixtures were
analyzed directly. Reaction conditions were as follows: T7 DNA
primase reaction buﬀer, DTT and BSA as given in Material and
Methods, 5mM CTP, 1mM GpppA (A) or
7MeGpppA (B),1 0 mM
DNA template CCCCGGGTCT25 (named dAC3) and 4mM T7 DNA
primase. Reactions were incubated at 378C for 6h. The ﬁrst section
(marked in gray) denotes the removal of proteic material and
remaining CTP by an on-line cleaning procedure using a pre-column.
The produced capped RNAs were then separated on the reverse-phase
C18 column. The gradient started after 5min at 100% eluent A with
an increase to 10% eluent B after 25min, reaching 30% after 35min
and 50% after 40min. Figure 2. Time course of capped RNA synthesis by T7 DNA primase
on DNA template dAC3 (CCCCGGGTCT25). Reaction conditions are
given in the legend of Figure 1. Samples were taken at the given time
points and analyzed by HPLC. The determination of yields
(pmol product per pmol enzyme) is detailed in Material and
Methods. (A) global analysis of substrate depletion (g GpppA,
f
7MeGpppA) and product generation (œ GpppACn,
 
7MeGpppACn) with time, (B) formation of individual products in
the GpppA-capped RNA product mixture (f GpppAC, g GpppAC2,
^ GpppAC3, œ GpppAC4, GpppAC5).
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(27) or pseudo-templated transcription where the
primase reiteratively transcribes a small homopolymeric
template stretch (30).
Variation of DNA template, CTP, cap analog and enzyme
concentration
The initially used conditions for the production of capped
RNA oligonucleotides were 5mM CTP, 1mM cap analog,
10mM DNA template CCCCGGGTCT25 (named dAC3)
and 4mM T7 DNA primase. Routinely, we obtained
overall conversions of 81–96% after 21h. In view of the
possibility to obtain a higher percentage of longer
products maintaining overall yields approaching 100%,
the inﬂuence of DNA template, CTP, cap analog
and enzyme concentration was studied.
The DNA template concentration was varied between
5 and 50mM. CTP and cap analog concentrations were
not varied in total independence because a higher
proportion of CTP than cap analog will always be
incorporated into the products. The ratio GpppA to
cytidine in product GpppAC5 for instance is 5 to 1.
We kept this ratio as a minimum and increased CTP
and GpppA concentration together from the starting
values 5 and 1mM to 20 and 4mM, respectively.
Furthermore, we kept the cap analog concentration at
1mM raising only the CTP concentration. Table 1 shows
the results of optimization using cap analog GpppA,
which were similar for
7MeGpppA reactions (not shown).
Note that there is a diﬀerence in substrate conversion
(81.2% versus 90.4%) between two identical reactions
(0.01mM DNA template and 5mM CTP/1mM GpppA,
respectively), which reﬂect the variations we obtained
between independent reaction series. Nevertheless product
distribution was always very similar.
The increase in DNA template concentration up to
50mM led to an increase in overall yield and product
length. Thus 50mM DNA template seems to be the
concentration of choice. On the other hand, it has to be
considered that template usage is much more eﬃcient
when lower concentrations are used. At 50mM DNA
template concentration, ca. 20pmol RNA oligonucleotide
are produced from one pmol DNA template, i.e. the
template is recycled 20 times supposing that all T7 DNA
primase molecules are active. This can be calculated from
the amount of total product generated (249.1 pmol per
pmol primase) and the amount of DNA of template used
in the reaction (12.5pmol per pmol primase). When 5 and
10mM DNA template is used, initiation happens 126
and 80 times, respectively, at each template molecule.
Increasing CTP and cap analog concentration at the
same time maintaining a ratio of 5 to 1 resulted in
a decrease in total yield and product length, thus both the
initiation and elongation part of the primase reaction seem
to be aﬀected drastically. When we increased the CTP
concentration alone, inhibition was stronger regarding
product formation in absolute terms (pmol product per
pmol enzyme) whereas product distribution essentially
stayed the same. Inhibition by CTP may be explained by
the formation of a dead-end complex by non-productive
binding between the enzyme and CTP (31) that prevents
productive binding of the cap analog. Activity seems to be
partially rescued by higher concentrations of cap analog.
However, higher cap analog concentrations result in lower
overall substrate conversion. In conclusion, CTP and cap
analog concentrations were kept at 5mM and 1mM,
respectively.
Enzyme concentration was varied between 1 and 8mM.
As shown in Figure 3, the overall yield and the length
of formed products increase with enzyme concentration
within the tested range (upper panel). Nevertheless,
the eﬃciency of the enzymatic reaction decreases
from 867.5pmol per pmol enzyme at 1mM to 125.0pmol
per pmol enzyme at 8mM enzyme concentration
(lower panel). In conclusion, 4mM T7 DNA primase
was kept as enzyme concentration for oligonucleotide
production on a preparative scale and further optimiza-
tion studies.
Variation of DNA template length and reaction time
In order to produce a series of capped RNA oligonucleo-
tides of diﬀerent length, several DNA templates
Table 1. Inﬂuence of DNA oligonucleotide dAC3 (CCCCGGGTCT25), CTP and GpppA concentrations on T7 DNA primase reaction yield and
product proﬁle. Standard reaction conditions were used as given in the legend to Figure 1 corresponding to the presence of 250 pmol of cap analog
substrate per pmol T7 DNA primase. The concentrations of DNA template and CTP/cap analog were then changed as given. Reactions were
incubated for 21h and analyzed by HPLC. Determination of yields of total product (pmol per pmol enzyme and percentage of substrate conversion)
and of single products (percentage of total product) is explained in Material and Methods
Variable Concentration Total product GpppACn GpppAC GpppAC2 GpppAC3 GpppAC4 GpppAC5
(mM) (pmol/pmol enzyme) (%) (% of total product)
DNA template 0.005 150.9 60.3 8.7 1.7 62.6 21.6 5.4
0.01 203.0 81.2 3.4 0.6 61.9 27.4 6.7
0.02 239.8 95.9 0.6 0.5 53.1 37.1 8.6
0.05 249.0 99.6 0 4.2 38.9 47.4 9.4
CTP/GpppA 5/1 222.9 90.4 1.8 0 62.4 28.8 7.1
10/2 130.5 26.1 30.3 4.8 54.9 10.0 0
20/4 47.5 4.7 77.7 8.7 13.6 0 0
10/1 65.3 26.2 31.3 5.1 52.2 10.0 1.4
20/1 25.2 10.1 58.2 7.7 29.3 4.7 0
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time was varied. Table 2 shows that the use of templates
dAC2 (C5GGTCT25) to dAC5 (C3GGGGGTCT25)
varying the reaction time between 21 and 71h allowed
the production of capped oligonucleotides
7MeGpppAC
to
7MeGpppAC9. In accordance with Figure 2, almost
identical results were obtained with GpppA as cap analog
(not shown). Highest yields (100 and 96.1%, respectively)
were obtained when DNA templates dAC2 and dAC3
were used. The main products after 21h corresponded
to
7MeGpppAC2 (75.2%) and
7MeGpppAC3 (72.1%),
respectively. As observed before, considerable amount
of (nþ1) products (21.2 and 23.6%, respectively) and
small amounts of (nþ2) products (3.6% and 4.2%,
respectively) were formed. With DNA templates dAC4
and dAC5, the overall yield of the reactions were lower
(78.1 and 55.7%, respectively). Yields could be increased
to a certain limit (93.4 and 70.6%, respectively) by
extending the reaction time to 48h. When dAC4 was
used, the main product after 21h was
7MeGpppAC4
(44.7%) but the (nþ1) product
7MeGpppAC5 after 48h
(50.5%). The (nþ1) product
7MeGpppAC6 was the main
product in the case of dAC5 after 21h (30.4%) and
remained so after 48h (33.9%). Allowing the reaction
using dAC5 to proceed further to 71h led to a negligible
increase in overall product yield and chain length.
In conclusion, an adequate DNA template and reaction
time of up to 48h can be chosen to produce a desired
spectrum of
(7Me)GpppACn (1 n 9). The chain length
distribution of the capped RNA oligonucleotides is wider
when DNA templates with longer guanine sequences are
used (dAC4 and dAC5).
Addition of fresh T7 DNA primase and CTP
Using dAC5, it was tested if yield and product chain
length could be increased by adding fresh enzyme after
48h and leaving the reaction to 71h. Additionally, CTP
was added to replenish free CTP thus trying to allow
synthesis of longer products but to avoid inhibition by
high CTP concentrations (see above). The addition of
enzyme alone increased the overall yield of the reaction
and product chain length only to a limited extend (76.3%
substrate conversion versus 73.7% without addition of
Figure 3. Inﬂuence of T7 DNA primase concentration on reaction yield
and product proﬁle. Standard reaction conditions were used as given in
the legend of Figure 1 except for T7 DNA primase concentration which
was varied between 1 and 8mM corresponding to the presence of 1000
and 125pmol of cap analog substrate (
7MeGpppA) per pmol T7 DNA
primase. DNA template was dAC3 (CCCCGGGTCT25). Reactions
were incubated for 21h and analyzed by HPLC as described in
Material and Methods. Yields in percentage conversion of cap analog
into each single product (upper panel) and pmol product per pmol
enzyme (lower panel) were determined as detailed in Material and
Methods. Total product represents the sum of conversion into
GpppAC3, GpppAC4 and GpppAC5. Amounts of GpppAC and
GpppAC2 products were negligible under the tested reaction conditions.
Table 2. Inﬂuence of DNA template length and reaction time on T7 DNA primase reaction yield and product proﬁle. Standard reaction conditions
were those given in the legend of Figure 1 corresponding to the presence of 250pmol of cap analog substrate per pmol T7 DNA primase. DNA
templates dAC2 to dAC5 correspond to CCCCCGGTCT25 to CCGGGGGTCT25, respectively. Reactions were incubated at 378C and analyzed by
HPLC as described in Material and Methods. Products are listed with the sequence following the cap
7MeG, e.g. AC stands for
7MeGpppAC. Yields
of total product (pmol per pmol enzyme and percentage conversion of substrate) and of single products (percentage of total product) were
determined as explained in Material and Methods
DNA template Reaction Time Total product
7MeGpppACn AC AC2 AC3 AC4 AC5 AC6 AC7 AC8 AC9
(h) (pmol/pmol enzyme) (%) (% of total product
7MeGpppACn)
dAC2 21 250.0 100 0 75.2 21.2 3.6 0 0 0 0 0
dAC3 21 240.3 96.1 0 0 72.1 23.6 4.2 0 0 0 0
dAC4 21 195.3 78.1 4.6 0 31.8 44.7 15.8 3.1 0 0 0
48 233.6 93.4 1.9 0.5 0 27.2 50.5 18.0 1.8 0 0
dAC5 21 139.2 55.7 17.8 6.5 4.9 0.4 21.1 30.4 15.7 3.1 0
48 176.6 70.6 9.9 3.5 2.7 0.3 19.3 33.9 22.7 6.5 1.2
71 179.3 71.7 9.1 3.1 1.6 0 13.5 35.3 27.3 8.2 1.9
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same time (the resulting CTP concentration was adjusted
to 2mM supposing that CTP had been consumed
completely), the overall yield decreased to 68.0% substrate
conversion but the product chain length was shifted
to longer products. After 71h,
7MeGpppAC8 represented
18% of total product instead of 8.2% without addition
of enzyme and CTP. When the amount of added CTP
was further increased (adjusted to 5mM concentration),
the reaction yield decreased further without increas-
ing the product length in comparison to 2mM.
Therefore if longer products are desired, the addition of
enzyme and CTP up to 2mM is beneﬁcial.
Synthesis of
(7Me)GpppACn on a preparative scale
Large-scale reactions (200ml reaction volume) were set up
using the optimized conditions described above, but trying
to use reasonable concentrations of enzyme and HPLC
grade DNA template (4 and 10mM, respectively).
Globally, no signiﬁcant diﬀerences in activity and product
distribution were observed between small (20ml) and large
(200ml) scale reactions (not shown). Parallel reactions
were set up to further increase production scale.
We used the DNA templates dAC2 and dAC3 for
the production of
(7Me)GpppAC2 and
(7Me)GpppAC3,
respectively, whereas dAC4 was used as the template
for the production of
(7Me)GpppAC4 to
(7Me)GpppAC7.
(7Me)GpppAC was puriﬁed as a minor product of the
dAC4 reaction. The reaction times were chosen to ensure
the best conversion rate of the starting material while
avoiding excessive distribution of the products, especially
for the shorter capped RNAs. After puriﬁcation, products
were lyophilized three times to remove the volatile buﬀer
solution. Each compound was characterized by mass
spectrometry and its purity conﬁrmed by HPLC (Table 3).
The isolated yields of each product after lyophilization
are given in Table 3. The best yields (42 and 52%) were
obtained for the dAC3 reactions where also a good
balance between conversion rate of the starting material
and low dispersion of the products could be obtained.
Slightly lower yields were obtained for the dAC2
reactions. As expected the global dispersion of the
products for the dAC4 series was the widest with the
advantage that this reaction aﬀorded reasonable amounts
of
(7Me)GpppAC and
(7Me)GpppAC4 to
(7Me)GpppAC7
to be produced. Thus we were able to produce a range
of short GpppA- or
7MeGpppA-capped RNA molecules
with yields up to 52% corresponding to ca. 100nmol
(corresponding to ca.2 0 mg) of product
7MeGpppAC3
starting from 200nmol cap analog. The obtained yields
may still be increased when higher DNA template
and enzyme concentrations are used and, concerning
longer products, when enzyme and CTP are added
after 48h (see above).
Chemical approaches (the advantage being that the
sequence can be varied) for the synthesis of short-capped
RNAs described in the literature gave isolated yields from
2 to 37%, as summarized by Koukhareva (8). Similar or
superior results have been obtained, at least for the main
products, using our enzymatic approach. Other strategies
to produce GpppA-capped RNA oligonucleotides,
which combine chemical synthesis of diphosphorylated
RNA followed by enzymatic addition of the cap by
commercially available guanylyltransferase (9), or use two
enzymatic reactions (synthesis of triphosphate poly(rA)
(32) followed by capping with guanylyltransferase (10)),
produced radiolabeled products for which no product
yields were given. Concerning one-pot enzymatic
reactions, E. coli as well as bacteriophage T7, SP6 and
T3 DdRps using their promoter sequences were reported
to have produced GpppA-capped RNA in microgram
range (12,13,16). Nevertheless 1mg of one these long
transcripts of ca. 2200 nucleotides (12) correspond to
65fmol of capped RNA and thus they are useful for
Table 3. Large-scale synthesis of short
(7Me)GpppA-capped RNAs starting from 200nmol of
(7Me)GpppA. DNA templates dAC2, dAC3 and dAC4
correspond to CCCCCGGTCT25, CCCCGGGTCT25 and CCCGGGGTCT25, respectively. For experimental conditions and MALDI-TOF
characterization, see Materials and Methods. Yields are given as isolated yields (percentage of substrate conversion and nmol or mg product
produced from 200nmol of cap analog) based on absorbance measurements of pure products after lyophilization. Given retention times correspond
to the use of the preparative gradient given in Material and Methods
Cap analog DNA template/
Reaction time
HPLC retention time Purity Isolated yields m/z exp. m/z calc.
(min) (%) (%) (nmol) (mg) negative mode
GpppAC dAC4/48h 27.9 100 2 4 12.9 1076.22 1076.58
GpppAC2 dAC2/15h 29.6 100 37 74 16.6 1382.23 1381.76
GpppAC3 dAC3/21h 31.2 100 42 84 20.2 1688.24 1686.94
GpppAC4 dAC4/48h 31.1 99 23 46 23.9 1991.42 1992.12
GpppAC5 dAC4/48h 33.3 100 21 42 27.6 2297.55 2297.31
GpppAC6 dAC4/48h 35.0 99 8 15 31.2 2601.81 2602.49
GpppAC7 dAC4/48h 36.4 91 1 2 34.9 2906.83 2907.67
7MeGpppAC dAC4/48h 26.7 99 2 3 13.1 1092.33 1090.61
7MeGpppAC2 dAC2/15h 28.7 100 31 61 16.8 1397.25 1395.79
7MeGpppAC3 dAC3/21h 30.7 99 52 103 20.4 1701.58 1700.97
7MeGpppAC4 dAC4/48h 31.9 100 13 26 24.1 2006.91 2006.15
7MeGpppAC5 dAC4/48h 32.9 100 34 68 27.7 2311.68 2311.33
7MeGpppAC6 dAC4/48h 34.5 100 17 33 31.4 2616.77 2616.51
7MeGpppAC7 dAC4/48h 36.0 98 2 3 35.1 2921.68 2921.69
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in enzymatic assays. Very recently, the T7 class II f2.5
promoter (14) was successfully used with T7 DdRp to
produce semi-puriﬁed GpppA-capped RNA transcripts
of ca. 180 nucleotides. No product yields were given.
The capped RNAs served as substrates in multiple-step,
radioactive Flavivirus MTase assays (15). This approach
oﬀers the advantage that sequence-speciﬁc RNA mole-
cules can be generated. It will be interesting to see
if it allows production of suﬃcient amounts for wider
biochemical, inhibition and crystallographic studies.
GpppA- and
7MeGpppA-capped RNAs as
methyltransferase substrates
The puriﬁed capped RNA oligonucleotides were tested as
substrates of Dengue 20OMTase, expressed as recombi-
nant N-terminal domain of protein NS5 (NS5MTaseDV)
in E. coli (6). In contrast to the usual set-up of
methyltransfer assays (15), we used non-radioactive
AdoMet and RNA substrate. The reaction mixture
was analyzed by reverse-phase HPLC including an
on-line cleaning procedure without any additional
sample treatment. Figure 4A shows the resulting proﬁle
after a 30-min reaction using GpppAC3 as substrate.
The retention time of substrate GpppAC3 was 30.6min.
An additional peak was observed at 35.4min. Its
molecular mass was determined by mass spectrometry as
being 1702.44 (m/z, [M H]
 ) compared to 1688.24 (m/z,
[M H]
 , see Table 3) of GpppAC3, thus one methyl
group was transferred. In order to identify the receiving
position, we digested the product at 35.4min by a mix
of nucleotide pyrophosphatase, phosphodiesterase I
and calf intestine phosphatase rendering the correspond-
ing nucleosides. The resulting mixture was analyzed by
HPLC (Figure 4B, lower chromatogram). The comparison
with standard compounds (upper chromatogram), which
was veriﬁed by co-injection (not shown), allowed
the identiﬁcation of 20O position of the adenosine as the
methylated position. Thus, in accordance with earlier
results using non-puriﬁed substrates (6), we found that
the product of methyltransfer by NS5MTaseDV using
substrate GpppAC3 corresponds to GpppA20OMeC3. Note
that the important delay in elution of GpppA20OMeC3
in comparison to substrate GpppAC3 is caused by an
increase in hydrophobicity due to the methylation of
the 20OH group combined with the use of a very shallow
Figure 4. Methyltransferase reactions using GpppAC3 as substrate.
(A): HPLC proﬁle of the NS5MTaseDV reaction mixture using
GpppAC3 as substrate. Reaction conditions are given in Material and
Methods. The crude enzymatic mixture was analyzed without sample
treatment. The ﬁrst section (in gray) indicates the removal of proteic
material and remaining AdoMet by on-line cleaning on the pre-column
(see Material and Methods). The gradient started after 5min at 100%
eluent A with an increase to 10% eluent B after 25min reaching 30%
after 45min. (B): HPLC proﬁle (lower chromatogram) of nucleoside
product mixture after enzymatic digestion of the product generated by
methylation of GpppAC3 by NS5MTaseDV (see panel A at 35.4min).
Enzymatic digestion was done using a mix of nucleotide pyrophos-
phatase, phosphodiesterase I and calf intestine phosphatase. The upper
chromatogram shows a mixture of standard compounds. No on-line
cleaning was used. The gradient started after 5min at 100% eluent A
with an increase to 10% eluent B after 25min and to 30% after 45min.
(C): HPLC proﬁle of the human mRNA cap N7MTase reaction
mixture using GpppAC3 as substrate (lower chromatogram) in
comparison to
7MeGpppAC3 being used as a control substrate (upper
chromatogram). Reaction conditions are given in Material and
Methods. The crude enzymatic mixtures were analyzed without
sample treatment as described in the legend of panel A.
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could also be achieved at the guanine-N7 position of
GpppAC3, we used recombinant human mRNA cap
N7MTase (33,34). The HPLC analysis of the reaction
products (Figure 4C, lower chromatogram) in comparison
to a control reaction using
7MeGpppAC3 (upper chroma-
togram) shows that GpppAC3 is indeed eﬃciently
methylated at the guanine-N7 position. Note that in this
case, a positive charge is generated upon methylation
leading to a shorter elution time of the product (29.3min)
in comparison to the non-methylated substrate (30.7min).
Thus both methyltransfer reactions were readily detect-
able by our HPLC separation method. They can be easily
analyzed in a quantitative way in terms of picomoles
methyl group transferred by one picomole enzyme.
CONCLUSION
We were able to produce and purify a series of GpppA-
capped RNA oligonucleotides of diﬀerent length,
(7Me)GpppACn (1 n 9), in a simple one-step enzymatic
reaction using a recombinant bacteriophage T7 DNA
primase fragment. Our yields (Table 2) correspond well to
the yield of 75% substrate conversion obtained upon
production of
7MeGpppACC using the full-length T7
DNA primase-helicase (17). In our study, we went further
in optimizing the production of longer molecules using
just the T7 DNA primase fragment. The isolated yields of
products
(7Me)GpppACn (1 n 7) obtained after large-
scale synthesis and puriﬁcation, in average 99% (Table 3),
are superior or comparable to other methods, the
additional advantage of the method presented here being
the simplicity at least for biochemical laboratories with
protein expression facilities. Moreover, this method allows
the production of highly puriﬁed and easily quantiﬁed
capped RNAs of diﬀerent lengths for (1) non-radioactive
activity assays, (2) studies of methyltransferase speciﬁcity
in relation to substrate length and (3) co-crystallization
studies of a variety of eukaryotic and viral methyltrans-
ferases and guanylyltransferases.
We showed that our puriﬁed capped RNA oligonucleo-
tides serve as substrate of a mRNA cap N7MTase and
a2 0OMTases of human origin and Dengue virus,
respectively. Both methyltransfer reactions were moni-
tored by a non-radioactive, quantitative HPLC assay.
In addition, our optimized method allows also the
production of di- or triphosphate RNA oligonucleotides
(using ATP or ADP instead of GpppA), which are
valuable tools for the biochemical and structural studies
of RNA triphosphatases and guanylyltransferases.
Besides, preliminary tests have shown that the production
of GpppACUCn and possibly other RNA oligonucleotides
varying at positions 3 and further are attainable
(not shown).
ACKNOWLEDGEMENTS
We wish to thank Charles C. Richardson (Harvard Medical
School, Boston, USA) and Aaron J. Shatkin (Center of
Advanced Biotechnology and Medicine, Piscataway, USA)
for kindly providing the T7 DNA primase expression
vector and the cDNA of human mRNA cap N7MTase,
respectively. We thank David Karlin for the production
of the T7 DNA primase as well as Marie-Pierre
Egloﬀ for puriﬁed NS5MTaseDV. This study was
supported, in part, by the integrated project VIZIER
(LSHG-CT-2004-511960) of the European Union 6th
PCRDT. F.P. was supported by a postdoctoral fellowship
from the Centre National de la Recherche Scientiﬁque
(CNRS), France. Funding to pay the Open Access
publication charge was provided by CNRS.
REFERENCES
1. Furuichi,Y. and Shatkin,A.J. (2000) Viral and cellular mRNA
capping: past and prospects. Adv. Virus Res., 55, 135–184.
2. Shuman,S. (2001) Structure, mechanism, and evolution of the
mRNA capping apparatus. Prog. Nucleic Acid Res. Mol. Biol., 66,
1–40.
3. Gould,E.A., de Lamballerie,X., Zanotto,P.M. and Holmes,E.C.
(2003) Origins, evolution, and vector/host coadaptations within the
genus Flavivirus. Adv. Virus Res., 59, 277–314.
4. Mackenzie,J.S., Gubler,D.J. and Petersen,L.R. (2004) Emerging
ﬂaviviruses: the spread and resurgence of Japanese encephalitis,
West Nile and dengue viruses. Nat. Med., 10, S98–109.
5. Benarroch,D., Egloﬀ,M.-P., Mulard,L., Guerreiro,C., Romette,J.-L.
and Canard,B. (2004) A structural basis for the inhibition of the
NS5 Dengue virus mRNA 20-O-methyltransferase domain by
ribavirin 50-triphosphate. J. Biol. Chem., 279, 35368–35643.
6. Egloﬀ,M.-P., Benarroch,D., Selisko,B., Romette,J.-L. and
Canard,B. (2002) An RNA cap (nucleoside-20-O-)-
methyltransferase in the ﬂavivirus RNA polymerase NS5: crystal
structure and functional characterization. EMBO J., 21, 2757–2768.
7. Jemielity,J., Heinonen,P., Lonnberg,H. and Darzynkiewicz,E.
(2005) A novel approach to solid phase chemical synthesis of
oligonucleotide mRNA cap analogs. Nucleosides, Nucleotides &
Nucleic Acids, 24, 601–605.
8. Koukhareva,I.I. and Lebedev,A.V. (2004) Chemical route to the
capped RNAs. Nucleosides, Nucleotides & Nucleic Acids , 23,
1667–1680.
9. Brownlee,G.G., Fodor,E., Pritlove,D.C., Gould,K.G. and
Dalluge,J.J. (1995) Solid phase synthesis of 50-diphosphorylated
oligoribonucleotides and their conversion to capped m7Gppp-
oligoribonucleotides for use as primers for inﬂuenza A virus RNA
polymerase in vitro. Nucleic Acids Res., 23, 2641–2647.
10. Shuman,S. (1989) Functional domains of vaccinia virus mRNA
capping enzyme. Analysis by limited tryptic digestion. J. Biol.
Chem., 264, 9690–9695.
11. Lockless,S.W., Cheng,H.-T., Hodel,A.E., Quiocho,F.A. and
Gershon,P.D. (1998) Recognition of capped RNA substrates
by VP39, the vaccinia virus-encoded mRNA cap-speciﬁc
20-O-methyltransferase. Biochemistry, 37, 8564–8574.
12. Holden,K.L. and Harris,E. (2004) Enhancement of dengue virus
translation: role of the 30 untranslated region and the terminal
30 stem-loop domain. Virology, 329, 119–133.
13. Yun,S.I., Kim,S.Y., Rice,C.M. and Lee,Y.M. (2003) Development
and application of a reverse genetics system for Japanese
encephalitis virus. J. Virol., 77, 6450–6465.
14. Coleman,T.M., Wang,G. and Huang,F. (2004) Superior 50 homo-
geneity of RNA from ATP-initiated transcription under the T7 phi
2.5 promoter. Nucleic Acids Res., 32, e14.
15. Ray,D., Shah,A., Tilgner,M., Guo,Y., Zhao,Y., Dong,H., Deas,T.S.,
Zhou,Y., Li,H. and Shi,P.Y. (2006) West nile virus 50-cap structure is
formed by sequential Guanine N-7 and ribose 20-O methylations by
nonstructural protein 5. J. Virol., 80, 8362–8370.
16. Contreras,R., Cheroutre,H., Degrave,W. and Fiers,W. (1982)
Simple, eﬃcient in vitro synthesis of capped RNA useful for direct
expression of cloned eukaryotic genes. Nucleic Acids Res., 10, 6353–
6362.
17. Matsuo,H., Moriguchi,T., Takagi,T., Kusakabe,T., Buratowski,S.,
Sekine,M., Kyogoku,Y. and Wagner,G. (2000) Eﬃcient synthesis of
e26 Nucleic Acids Research, 2007, Vol. 35, No. 4 PAGE 10 OF 1113C,
15N-labeled RNA containing the cap structure m
7GpppA.
J. Am. Chem. Soc., 122, 2417–2421.
18. Kato,M., Ito,T., Wagner,G., Richardson,C.C. and Ellenberger,T.
(2003) Modular architecture of the bacteriophage T7 primase
couples RNA primer synthesis to DNA synthesis. Mol. Cell, 11,
1349–1360.
19. Frick,D.N., Baradaran,K. and Richardson,C.C. (1998) An
N-terminal fragment of the gene 4 helicase/primase of bacterio-
phage T7 retains primase activity in the absence of helicase activity.
Proc. Natl. Acad. Sci. U.S.A., 95, 7957–7962.
20. Dawson,R.M.C., Elliott,D.C., Elliott,W.H. and Jones,K.M. (1986)
Data for Biochemical Research, Oxford University Press, Oxford.
21. Cantor,C.R., Warshaw,M.M. and Shapiro,H. (1970)
Oligonucleotide interactions. 3. Circular dichroism studies of
the conformation of deoxyoligonucleotides. Biopolymers, 9,
1059–1077.
22. Mendelman,L.V. and Richardson,C.C. (1991) Requirements for
primer synthesis by bacteriophages T7 63-kDa gene 4 protein.
J. Biol. Chem., 266, 23240–23250.
23. Kusakabe,T. and Richardson,C.C. (1997) Gene 4 DNA primase
of bacteriophage T7 mediates the annealing and extension of
ribo-oligonucleotides at primase recognition sites. J. Biol. Chem.,
272, 12446–12453.
24. Pompon,A., Lefebvre,I., Imbach,J.-L., Kahn,S. and Farquhar,D.
(1994) Decomposition pathways of the mono- and bis(pivaloyloxy
methyl) esters of azidothymidine 50-monophosphate in cell extract
and in tissue culture medium: an application of the ‘on-line IRSP-
cleaning’ HPLC technique. Antivir. Chem. Chemother., 5, 91–98.
25. Pompon,A., Lefebvre,I. and Imbach,J.L. (1992) ‘On-line internal
surface reversed-phase cleaning’: the direct HPLC analysis of crude
biological samples. Application to the kinetics of degradation of
oligonucleotides in cell culture medium. Biochem. Pharmacol., 43,
1769–1775.
26. Frick,D.N. and Richardson,C.C. (1999) Interaction of bacterio-
phage T7 gene 4 primase with its template recognition site. J. Biol.
Chem., 274, 35889–35898.
27. Kusakabe,T. and Richardson,C.C. (1997) Template recognition and
ribonucleotide speciﬁcity of the DNA primase of bacteriophage T7.
J. Biol. Chem., 272, 5943–5951.
28. Frick,D.N., Kumar,S. and Richardson,C.C. (1999) Interaction
of ribonucleotide triphosphates with the gene 4 primase of
bacteriophage T7. J. Biol. Chem., 274, 35899–35907.
29. Qimron,U., Lee,S.J., Hamdan,S.M. and Richardson,C.C. (2006)
Primer initiation and extension by T7 DNA primase. EMBO J., 25,
2199–2208.
30. Jacques,J.P. and Kolakofsky,D. (1991) Pseudo-templated tran-
scription in prokaryotic and eukaryotic organisms. Genes Dev., 5,
707–713.
31. Cornish-Bowden,A. (2004) Fundamentals of Enzyme Kinetics.
3rd Edn., Portland Press, Oxford.
32. Venkatesan,S. and Moss,B. (1980) Donor and acceptor speciﬁcities
of HeLa cell mRNA guanylyltransferase. J. Biol. Chem., 255,
2835–2842.
33. Pillutla,R.C., Yue,Z., Maldonado,E. and Shatkin,A.J. (1998)
Recombinant human mRNA cap methyltransferase binds capping
enzyme/RNA polymerase IIo complexes. J. Biol. Chem., 273,
21443–21446.
34. Saha,N., Schwer,B. and Shuman,S. (1999) Characterization of
human, Schizosaccharomyces pombe, and Candida albicans mRNA
cap methyltransferases and complete replacement of the yeast
capping apparatus by mammalian enzymes. J. Biol. Chem., 274,
16553–16562.
PAGE 11 OF 11 Nucleic Acids Research, 2007, Vol. 35, No. 4 e26